These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36332007)

  • 1. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration.
    Hammer ASB; Juul-Dam KL; Sandahl JD; Abrahamsson J; Czogala M; Delabesse E; Haltrich I; Jahnukainen K; Kolb EA; Kovács G; Leverger G; Locatelli F; Masetti R; Noren-Nyström U; Raimondi SC; Rasche M; Reinhardt D; Taki T; Tomizawa D; Zeller B; Hasle H; Kjeldsen E
    Blood Adv; 2023 Mar; 7(6):1045-1055. PubMed ID: 36332007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.
    Rasche M; von Neuhoff C; Dworzak M; Bourquin JP; Bradtke J; Göhring G; Escherich G; Fleischhack G; Graf N; Gruhn B; Haas OA; Klingebiel T; Kremens B; Lehrnbecher T; von Stackelberg A; Tchinda J; Zemanova Z; Thiede C; von Neuhoff N; Zimmermann M; Creutzig U; Reinhardt D
    Leukemia; 2017 Dec; 31(12):2807-2814. PubMed ID: 28443606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood
    van Weelderen RE; Klein K; Harrison CJ; Jiang Y; Abrahamsson J; Arad-Cohen N; Bart-Delabesse E; Buldini B; De Moerloose B; Dworzak MN; Elitzur S; Fernández Navarro JM; Gerbing RB; Goemans BF; de Groot-Kruseman HA; Guest E; Ha SY; Hasle H; Kelaidi C; Lapillonne H; Leverger G; Locatelli F; Masetti R; Miyamura T; Norén-Nyström U; Polychronopoulou S; Rasche M; Rubnitz JE; Stary J; Tierens A; Tomizawa D; Zwaan CM; Kaspers GJL
    J Clin Oncol; 2023 Jun; 41(16):2963-2974. PubMed ID: 36996387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosomal karyotype is not a predictor of dismal outcome in childhood de novo acute myeloid leukemia.
    Lee NH; Choi YB; Yi ES; Lee SH; Kim HJ; Lee JW; Sung KW; Koo HH; Yoo KH
    Leuk Res; 2016 Nov; 50():57-62. PubMed ID: 27683973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
    J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group.
    McNeer JL; Devidas M; Dai Y; Carroll AJ; Heerema NA; Gastier-Foster JM; Kahwash SB; Borowitz MJ; Wood BL; Larsen E; Maloney KW; Mattano L; Winick NJ; Schultz KR; Hunger SP; Carroll WL; Loh ML; Raetz EA
    J Clin Oncol; 2019 Apr; 37(10):780-789. PubMed ID: 30742559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT).
    Poiré X; Labopin M; Cornelissen JJ; Volin L; Richard Espiga C; Veelken JH; Milpied N; Cahn JY; Yacoub-Agha I; van Imhoff GW; Michallet M; Michaux L; Nagler A; Mohty M
    Am J Hematol; 2015 Aug; 90(8):719-24. PubMed ID: 26010466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
    Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
    J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study.
    Sandahl JD; Kjeldsen E; Abrahamsson J; Ha SY; Heldrup J; Jahnukainen K; Jónsson OG; Lausen B; Palle J; Zeller B; Forestier E; Hasle H
    Genes Chromosomes Cancer; 2014 Aug; 53(8):667-75. PubMed ID: 24753324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Münster Chemotherapy in Adult Acute Lymphoblastic Leukemia.
    Aladag E; Aktimur SH; Aydın Ö; Demiroglu H; Buyukasik Y; Aksu S; Ozcebe OI; Haznedaroglu IC; Sayinalp N; Turgut M; Goker H
    Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):147-153. PubMed ID: 33451957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monosomal karyotype affecting outcomes of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission.
    Choi Y; Lee JH; Lee JH; Park HS; Choi EJ; Jo JC; Lee YJ; Lee YS; Kang YA; Lee KH
    Eur J Haematol; 2020 Sep; 105(3):262-273. PubMed ID: 32353911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.
    Nachman JB; Heerema NA; Sather H; Camitta B; Forestier E; Harrison CJ; Dastugue N; Schrappe M; Pui CH; Basso G; Silverman LB; Janka-Schaub GE
    Blood; 2007 Aug; 110(4):1112-5. PubMed ID: 17473063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
    Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
    J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.
    Klusmann JH; Reinhardt D; Zimmermann M; Kremens B; Vormoor J; Dworzak M; Creutzig U; Klingebiel T
    Haematologica; 2012 Jan; 97(1):21-9. PubMed ID: 21933851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
    Noort S; Zimmermann M; Reinhardt D; Cuccuini W; Pigazzi M; Smith J; Ries RE; Alonzo TA; Hirsch B; Tomizawa D; Locatelli F; Gruber TA; Raimondi S; Sonneveld E; Cheuk DK; Dworzak M; Stary J; Abrahamsson J; Arad-Cohen N; Czogala M; De Moerloose B; Hasle H; Meshinchi S; van den Heuvel-Eibrink M; Zwaan CM
    Blood; 2018 Oct; 132(15):1584-1592. PubMed ID: 30150206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
    Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
    Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study.
    Bager N; Juul-Dam KL; Sandahl JD; Abrahamsson J; Beverloo B; de Bont ESJM; Ha SY; Jahnukainen K; Jónsson ÓG; Kaspers GL; Kovalova Z; Lausen B; De Moerloose B; Noren-Nyström U; Palle J; Saks K; Zeller B; Kjeldsen E; Hasle H
    Br J Haematol; 2018 Nov; 183(4):618-628. PubMed ID: 30406946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.